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The association between anemia and postpartum 
depression: A systematic review and meta-analysis 
 
 
Abstract 
Background: The association between anemia and postpartum depression (PPD) has been 
reported to be controversial in different studies. Therefore, this study aimed to provide a 
comprehensive assessment of anemia and PPD. 
Methods: This review study was conducted according to the MOOSE protocol and results 
have been reported according to the PRISMA guideline. We searched epidemiologic 
studies published until January 2018 in nine English databases including Scopus, 
PubMed/Medline, Science Direct, Embase, Web of Science, CINAHL, Cochrane Library, 
EBSCO and Google Scholar using English MeSH keywords. The heterogeneity of the 
studies was assessed using the Cochran’s Q test and I2 index. Data were analyzed using a 
random effects model and comprehensive meta-analysis (CMA) software version 2. 
Results: In the 10 studies, the association between postpartum anemia and PPD was 
significant (heterogeneity test: P<0.001, I
2
=74.62%), and RR=1.887 (95%CI: 1.255-2.838, 
P=0.002). In 8 studies, anemia during pregnancy significantly increased the risk of 
postpartum depression (heterogeneity test: P=0.116, I
2
=36.422%), RR=1.240 (1.001-
1.536, P=0.048). The subgroup analysis of postpartum anemia and PPD was not significant 
for the variables of quality of studies, study design, and the period of evaluating depression 
and anemia. The subgroup analysis of anemia during pregnancy and PPD was not 
significant for the period of evaluating depression. Publication bias did not affect the 
results of the studies. 
Conclusion: Meta-analysis results showed anemia during pregnancy and after pregnancy 
that significantly increased the risk of postpartum depression. Therefore, prevention, 
identification and treatment of anemia in pregnant women seem necessary. 
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Anemia is one of the most important public health issues worldwide, which has a 
great impact on the physical, mental ability of people at work, and is the most common 
type of iron-deficiency anemia (1); about 80% of non-physiologic anemia during 
pregnancy occurs due to iron deficiency (2). Therefore, paying attention to the nutritional 
status of women during pregnancy is very important. The prevalence of anemia in 
pregnant women is affected by geographical region, lifestyle, and diet, and is reported to 
be between 14-80% in different societies (3-5). The effect of anemia on the adverse 
pregnancy outcomes, including pre-eclampsia, premature rupture of membranes, low birth 
weight, preterm birth, fetal and maternal deaths have been shown in various studies (6-8). 
Depression during pregnancy and PPD are one of the most common problems in pregnant 
women (9). 
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The cause of this problem is associated with genetics, 
history of mental illness, and physiological, psychological 
and social changes, hormonal changes, physical discomfort 
such as nausea and vomiting, fatigue, sudden pain during 
pregnancy, and is also associated with the health of the fetus 
and even the mode of delivery (10). Depression has short-
term and long-term effects on mother and fetus, including 
high-risk behaviors, preeclampsia, negative pregnancy 
outcomes such as low birth weight, prematurity, small head 
circumference and increased PPD (11-14). Additionally, 
depression during pregnancy is also related to a range of 
other negative outcomes such as social isolation (10), marital 
conflicts (15), delayed motor skills or intellectual 
development in the infant (16), embryonic growth 
restriction, and high stress response in newborn at delivery 
(17, 18). Various studies have investigated the association 
between anemia and PPD, and the results of these studies are 
diverse (19-23) and no meta-analysis on this topic is 
available. Thus, a systematic review and meta-analysis 
seems necessary. 
Obviously, in meta-analytical methods, by collecting data 
from several studies, the number of samples is greater and 
therefore, the range of variations and probabilities is 
reduced. As a result, the significance of statistical findings 
increases (24-27). On the other hand, the motto of the World 
Health Organization in 2017 (Depression: Let's Talk) 
emphasizes global attention to the issue of depression. The 
present study aimed to investigate the association between 
anemia and PPD. 
 
 
Methods 
Study protocol: This review study was conducted on the 
basis of the Meta-analysis of observational studies in 
epidemiology (MOOSE) protocol and results were reported 
according to the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) guideline for 
systematic review and meta-analysis (27). All the steps of 
study were taken by two researchers independently. In cases 
of disagreement, a third researcher helped reach an 
agreement.  
Search strategy: We searched epidemiologic studies 
published until January 2018 without time limit in nine 
English databases including Scopus, PubMed/Medline, 
Science Direct, Embase, Web of Science (ISI), CINAHL, 
Cochrane Library, EBSCO and Google Scholar search 
engine using English MeSH keywords: Anemia, Anaemia, 
Hemoglobin, Ferritin, Pregnancy, Pregnant Woman, Prenatal 
Care, Complications of Pregnancy, Postpartum Depression, 
Mental Disorders, and Mental Health. A combination of 
words was used with functions “AND” and “OR”. An 
example of the PubMed search strategy is shown in 
Appendix 1. A manual search was also done using the 
reference list of articles searched on the above-mentioned 
websites.  
Inclusion and exclusion criteria: Inclusion criteria 
according to PICO (related to evidence-based medicine) 
(28): 1) Population: epidemiologic studies (cross-sectional, 
cohort and case studies) that investigated the association 
between anemia during pregnancy or postpartum anemia and 
PPD; 2) Intervention: hematological test to confirm anemia 
and questionnaire to confirm PPD; 3) Comparison: That 
shows the rate of PPD prevalence in anemic patients 
compared to non-anemic patients; 4) Outcome: Estimate the 
association between anemia and PPD.  
Exclusion criteria were: 1) sample size other than 
pregnant women or postpartum women; 2) sample size with 
a history of mental illness or use of antidepressants; 3) letters 
to the Editor without original data, review and case report 
and 4) duplicate studies. 
Qualitative assessment: The modified Newcastle Ottawa 
Scale (NOS) for cross-sectional studies (29) was used to 
assess the quality of the studies. The quality of the studies 
was divided into three categories: unsatisfactory (less than 5 
points), satisfactory (5-6 points) and good or very good (7-10 
points). Finally, the points given to the articles were 
compared by two researchers and a general discussion was 
carried out in cases of disagreement. The minimum score for 
entering the meta-analysis process was 5. 
Data extraction: For data extraction, a premade checklist, 
including the name of the author (s), year of study, place of 
study, study design, sample size (total, case and control), 
mean and SD (standard deviation) for hemoglobin in case 
and control groups, P-value for correlation, age (mean±SD), 
gestational age (mean±SD), anemia cut-off point, depression 
diagnostic tool, depression cut-off point, and odds ratio (OR) 
or relative risk (RR) with 95% confidence interval (CI) was 
used. 
Grading of evidence: We categorized the overall 
methodological quality of each distributed analysis using the 
Grading of Recommendations Assessment, Development 
and Evaluation (short GRADE), while taking into account 
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study limitations (risk of bias), inconsistency, imprecision, 
and indirectness, and publication bias (30). Then, the quality 
of evidence was divided into high, moderate, low or very 
low. 
Statistical analysis: The results of the study were analyzed 
using Comprehensive Meta-Analysis (CMA) Version 2. For 
calculating RR and 95% CI, we used: 1) Event rate and total 
sample size for each of the groups (case and control) in the 
studies of Parhizkar (31), Akbari (32), Eckerdal (33), 
Paterson (34); 2) P-value and sample size for correlation in 
the studies of Goshtasebi (20) and Corwin (21); 3) Mean, SD 
and sample size for each of the groups in the study of 
Armony (22); and 4) in the study of Alharbi (23), RR and 
95% CI were reported. Finally, the RRS and 95% CI were 
combined for meta-analysis. The heterogeneity of the studies 
was assessed using the Cochran’s Q test and I2 index. In this 
regard, interpretation was as follows: (0-24% may not be 
important, 25-49% may indicate moderate heterogeneity, 50-
75% indicate substantial heterogeneity and over 75% 
indicate considerable heterogeneity) (35). Therefore, we 
observed statistical heterogeneity, and thus, random effects 
model was used (36). A subgroup analysis was conducted to 
find out the cause of heterogeneity. Sensitivity analysis was 
also performed. The Begg and Egger’s tests were used to 
assess the publication bias. The significance level of the test 
was considered to be p<0.05. 
 
 
Results 
Study characteristics and methodological quality: The 
process of study selection is shown in figure 1. In this 
systematic study, 348 articles were identified based on an 
initial search by two researchers. 174 duplicate studies were 
excluded. 150 irrelevant studies were excluded. After final 
evaluation and review, 14 studies were excluded due to: 
sample size other than pregnant women or postpartum 
women (N=9); sample size with a history of mental illness or 
the use of antidepressants (N=2); letters to the editor without 
original data, reviews and case reports (N=3). Finally, 10 
studies [10 studies for postpartum anemia and PD and 8 
studies for anemia during pregnancy and PPD] entered the 
quantitative meta-analysis process. The mean age of the 
participants in the study was 28.16 years (95% CI: 25.30 - 
31.03). Other characteristics of studies are summarized in 
table 1. 
 
 
 
Figure 1: PRISMA flowchart 
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Table 1. Summary characteristics of studies entered into the meta-analysis  
 
1: Postpartum anemia on postpartum depression; 2: Anemia during pregnancy and postpartum depression. RR; Relative risk, OR; Odds ratio, CI: Confidence 
interval, W; week, H; hours, * RR/ OR and 95% CI was estimated. 
** Repetitive studies have been included and estimate the relation between anemia and postpartum depression for more than survey (anemia during pregnancy or 
postpartum anemia), more than one sample size or also different time point of postpartum depression or anemia. 
 
The association between postpartum anemia and PPD: In 
10 studies, PPD was significantly higher in anemic women 
than non-anemic women based on the random effects model 
(heterogeneity test: P< 0.001, I
2 =
 74.62%), and RR= 1.887 
(95% CI: 1.255-2.838, P= 0.002) (figure 2-A). In figure 2-B, 
this association is shown by omitting one study at a time, and 
the results showed that the overall estimate was strong 
(sensitivity analysis). 
 
The association between anemia during pregnancy and 
PPD: In 8 studies, anemia during pregnancy significantly 
increased the risk of PPD (heterogeneity test: P= 0.116, I
2  
= 
36.422%), RR= 1.240 (95% CI: 1.001-1.536, P= 0.048) 
(figure 2). Figure 3-B shows the sensitivity analysis and the 
results showed that the overall estimate was strong. 
Subgroup analysis: The subgroup analysis of postpartum 
anemia and PPD was not significant for the variables of 
Ref 
First 
author, 
Published 
year 
Survey Design Place 
Sample size 
Tool for  
depression 
Time point of Cut-off point 
RR/ 
OR* 
(95%CI)* 
Quality 
Case Control 
postpartum 
depression 
Anemia depression anemia Lower Upper 
(20) 
Goshtasebi, 
2013 
1 Cohort Iran 14 240 EPDS At 4-6 W 
4-6 W  
postpartum 
13 11 3.746 1.178 11.906 Satisfactory 
(21) 
Corwin, 
2003 
1 Cohort America 8 29 CES-D At 4 W 
At 7 and 
14 days 
postpartum 
16 12 5.846 1.337 25.56 Satisfactory 
(22) 
Armony, 
2012 
1 Cohort China 140 124 EPDS At 24–48 h 
At 3th 
days 
postpartum 
10 11 1.0 0.645 1.55 Good 
(22) 
Armony, 
2012** 
1 Cohort China 130 118 EPDS At 6 W 
At 3 days 
postpartum 
10 11 0.797 0.507 1.253 Good 
(31) 
Parhizkar, 
2012 
1 
Cross 
sectional 
Iran 316 84 EPDS At 4 W 
At 7th  day 
postpartum  
10 12 2.016 1.23 3.305 Satisfactory 
(23) 
Alharbi, 
2014 
1 Cohort 
Saudi 
Arabia 
166 186 EPDS 8- 12 W 
At 8–12 W 
postpartum 
10 11 1.7 1.05 2.74 Good 
(32) 
Akbari, 
2008 
1 Cohort Iran 28 81 EPDS At 4 W 
At 7th 
postpartum 
day 
10 11 3.22 1.494 6.941 Good 
(32) 
Akbari, 
2008 
1 Cohort Iran 29 96 EPDS At 4 W 
At 4 W  
postpartum 
10 11 6.591 2.962 14.667 Good 
(33) 
Eckerdal, 
2016 
2 Cohort Sweden 106 340 EPDS At 6 W 
At 6-8 W  
postpartum 
12 11 1.107 0.371 3.296 Good 
(34) 
Paterson, 
1994 
1 
Cross 
sectional 
United 
kingdom 
251 598 EPDS At 10th day 
At 10th 
day 
postpartum 
14 10.5 1.331 0.791 2.241 Satisfactory 
(22) 
Armony, 
2012 
2 Cohort China 12 125 EPDS At 6 W 
Early/mid 
pregnancy 
10 11 1.278 0.436 3.744 Good 
(22) 
Armony, 
2012 
2 Cohort China 54 81 EPDS 6 W 
Late 
pregnancy 
10 11 1.278 0.684 2.389 Good 
(22) 
Armony, 
2012 
2 Cohort China 72 483 EPDS At 24–48 h 
Early/mid 
pregnancy 
10 11 0.919 0.584 1.439 Good 
(22) 
Armony, 
2012 
2 Cohort China 71 417 EPDS At 6 W 
Early/mid 
pregnancy 
10 11 0.736 0.466 1.162 Good 
(22) 
Armony, 
2012 
2 Cohort China 181 366 EPDS At 24–48 h 
Late 
pregnancy 
10 11 1.35 0.977 1.865 Good 
(22) 
Armony, 
2012 
2 Cohort China 165 315 EPDS At 6 W 
Late 
pregnancy 
10 11 1.247 0.886 1.756 Good 
(32) 
Akbari, 
2008 
1 Cohort Iran   EPDS At 4 W 
38-40 W 
pregnancy 
10 11 1.8 1.2 2.7 Good 
(33) 
Eckerdal, 
2016 
1 Cohort Sweden 31 412 EPDS At 6 W 
During 
pregnancy 
11 12 1.782 0.963 3.3 Good 
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geographic regions (P=0.113), study design (P=0.545), 
quality of the studies (P=0.604), and the period of evaluating 
depression (P=0.604) and anemia (P= 0.261) (table 2). The 
subgroup analysis of anemia during pregnancy and PPD was 
not significant for the period of evaluating depression (P= 
0.588) (table 2). 
 
Table 2: Subgroup analysis of anemia and postpartum depression 
PValue RR 95% CI 
Heterogeneity 
Study(N) Variable 
I2 (%) PValue df Q 
0.009 1.973 
1.185-
3.285 
81.054 < 0.001 6 31.668 7 Asia 
Regions 
Postpartum anemia  
0.019 5.846 
1.337-
25.561 
0 - 0 0 1 America 
0.294 1.286 
0.804-
2.058 
0 0.765 1 0.089 2 Europe 
Test for subgroup differences: Q= 4.366, df(Q)= 2, P= 0.113 
0.10 2.038 
1.182-
3.514 
79.399 < 0.001 7 33.979 8 Cohort 
Study design 
0.016 1.652 
1.100-
2.481 
22.172 22.172 1 1.285 2 
Cross 
sectional 
Test for subgroup differences: Q= 0.366, df(Q)= 1, P= 0.545 
0.070 1.716 
0.957-
3.076 
82.115 < 0.001 5 27.957 6 Good 
Quality of the studies 
0.004 2.107 
1.264-
3.510 
44.465 0.145 3 5.402 4 Satisfactory 
Test for subgroup differences: Q= 0.270, df(Q)= 1, P= 0.604 
0.280 1.392 
0.764-
2.538 
66.217 0.031 3 8.880 4 ≤ 4 W 
Time point of  
postpartum depression 
0.004 2.312 
1.310-
4.080 
78.412 <0.0001 5 23.161 6 > 4 W 
Test for subgroup differences: Q= 1.447, df(Q)= 1, P= 0.229 
0.017 2.604 
1.188-
5.705 
71.653 0.014 3 10.583 4 ≤ 2 W 
Time point of  
postpartum anemia 
0.061 1.548 
0.980-
2.444 
72.569 0.003 5 18.228 6 > 2 W 
Test for subgroup differences: Q= 1.261, df(Q)= 1, P= 0.261 
0.312 1.167 
0.866-
1.572 
32.994 0.201 4 5.970 5 ≤ 4 W 
Time point of  
postpartum depression 
Anemia during 
pregnancy* 0.112 1.324 
0.936-
1.872 
57.667 0.094 2 4.724 3 > 4 W 
Test for subgroup differences: Q= 0.294, df(Q)= 1, P= 0.588 
N; Number, RR; relative risk, W; week, CI; Confidence interval, Q; Q test for heterogeneity, df; degrees of freedom, and I2; I square.* We could not do other 
subgroup analysis 
 
Publication bias: Publication bias for postpartum anemia 
and PPD was shown as a funnel plot, and p-value for Egger 
and Begg’s tests were 0.0528 and 0.0736, respectively, 
indicating that publication bias did not affect the results of 
the studies. Egger (p=0.710) and Begg’s (p=0.956) tests  
 
 
were not significant for anemia during pregnancy and PPD 
(figure 4). 
Grading of evidence: According to GRADE summaries, we 
considered the quality of the evidence to be moderate for all 
outcomes. GRADE summaries were provided in table 3. 
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Figure 2: The association of postpartum anemia and postpartum depression (A) and sensitivity analysis with removed one 
study (B). Random effects model. CI; Confidence interval 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: The association of anemia during pregnancy and postpartum depression (A) and sensitivity with one study 
removed analysis (B), Random effects model.  CI: Confidence interval 
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Figure 4: Publication bias for studies of postpartum anemia (A) and anemia during pregnancy (B) on postpartum depression 
 
Table 3: GRADE assessment of confidence in effect estimates  
Outcome Risk of bias Consistency Directness Precision Publication bias Quality 
postpartum anemia on 
PPD 
No serious 
limitations 
Serious 
limitations
a
 
No serious 
limitations 
No serious 
limitations 
No serious 
limitations 
Moderate 
Anemia during 
pregnancy on PPD 
No serious 
limitations 
Serious 
limitations
b
 
No serious 
limitations 
No serious 
limitations 
No serious 
limitations 
Moderate 
GRADE; Grading of Recommendations Assessment, Development and Evaluation                                                         a Considerable heterogeneity: I2 = 74.62%        
b Moderate heterogeneity: I2 = 36.42% 
 
Discussion 
The present study is the first systematic review and meta-
analysis of the association between anemia and PPD. The 
results of the association between anemia and PPD were not 
similar in different studies; in the studies of Armony et al. 
(2012) (22), Eckerdal et al. (2016) (33) and Paterson et al. 
(1994) (34), this association was not significant, but it was 
significant in the studies of Akbari et al. (2008) (32), Alharbi 
et al. (2014) (23) and Corwin et al. (2003) (21). Based on the  
 
results of this study, PPD was significantly higher in anemic 
women versus non-anemic women with RR= 1.887 and 
P=0.002. Moreover, the association between anemia during 
pregnancy and PPD was significant (RR= 1.39 [1.15-1.68], 
P=0.001). Although these are primary studies in this field, 
the final decision on whether or not anemia has been 
associated with depression in women during pregnancy and 
after pregnancy has not been made. In this study, according 
to the systematic review of all the documents and their 
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combination by meta-analysis, this association was 
investigated, which indicated the existence of the 
association. Subgroup analysis to find out the cause of 
heterogeneity revealed that quality of studies, study design, 
timing of depression and anemia are not the influenced 
factors. Some studies indicated the depression during 
pregnancy and PPD were associated with thyroid disorders 
and gestational diabetes (37-39). Anemia during pregnancy 
and after pregnancy significantly increased the risk of 
postpartum depression. Hemoglobin decline may change the 
function of neurotransmitters and subsequently alter the 
cellular, oxidative and thyroid hormones metabolism. In 
addition, the reduction of inflammatory cytokines, such as 
interleukin 2, as causative agents for anemia, can be an 
influencing factor in depression. Therefore, anemia during 
pregnancy and after pregnancy may be one of the causes of 
depression by altering inflammatory cytokines (21). 
However, according to the findings of this study, PPD was 
significantly higher in anemic women versus non-anemic 
women, and there was a significant association between 
anemia during pregnancy and PPD. Although, the main 
causes of PPD in clinical sciences are not yet known (21, 37-
40). In another study, the symptoms of depression ranged 
from 48 hours after pregnancy to 32 weeks after pregnancy 
were examined in 821 women with low serum ferritin levels. 
They showed that if serum ferritin was about 1 μg, the risk of 
PPD would increase by 3.98 times (41). In another study, 
bleeding more than 1000 ml after childbirth increased the 
chance of anemia and increased the risk of depression by 2.1 
times (34).  
In other studies, fatigue has been mentioned as one of the 
causes of depression; fatigue indicates a decrease in body 
energy levels and, consequently, the level of activity 
decreases to reduce energy consumption and to achieve 
balance. Increasing metabolic needs can explain the fatigue 
associated with pregnancy and postpartum period, and in this 
case, the higher the fatigue of the mother, the greater the 
likelihood of depression (42, 43). In investigation of the role 
of hormones in depression in pregnant and postpartum 
women, no major physiological hormone differences have 
been observed in women with PPD (21). In addition to 
physiological changes, sexual abuse, history of 
neurodegenerative disease or depression among relatives, 
especially close relatives, neglect from the spouse and 
relatives of the pregnant woman, fear of childbirth, marital 
problems, especially emotional and economic problems, low 
age of mother, marriage forced by parents, disinterest toward 
spouse and unwanted pregnancy can be other causes of 
depression during pregnancy and after childbirth (21, 44, 
45). Publication bias for postpartum anemia on PPD studies 
has been shown as a funnel graph, and p-value for Egger’s 
and Begg’s tests were 0.06 and 0.08, respectively, indicating 
that publication bias did not affect the results of the studies. 
For anemia during pregnancy and PPD, Egger (0.826) and 
Begg’s (0.999) tests were not significant. It is assumed that 
the observed differences are due to different sampling and 
also the difference in the measured parameters in different 
societies. According to the World Health Organization's 
motto in 2017 (Depression: Let's talk), depression is a 
common emotional disorder and should be considered as a 
global health problem in all countries and societies. Family 
quality of life, early diagnosis of the disease in early weeks 
after delivery and early treatment are important (20, 46). 
Therefore, the study and treatment of anemia during 
pregnancy and after pregnancy can be an important 
preventive and therapeutic measure. 
One of the limitations of this study is the lack of access 
to the Gray literature of different countries for the collection 
of more basic studies and more detailed examination. 
In Conclusion, Meta-analysis results showed a significant 
association between anemia (during pregnancy and 
postpartum) and PPD. Therefore, prevention, identification 
and treatment of anemia in pregnant women seem necessary. 
Appendix 1: PubMed search strategy 
1. Anemia [Title, Abstract] 
2. Anaemia [Title, Abstract] 
3. Hemoglobin [Title, Abstract] 
4. Ferritin [Title, Abstract] 
5. Pregnancy [Title, Abstract] 
6. Pregnant Woman [Title, Abstract] 
7. Prenatal Care [Title, Abstract] 
8. Complications of Pregnancy [Title, Abstract] 
9. Depression [Title, Abstract] 
10. Postpartum Depression [Title, Abstract] 
11. Mental Disorders [Title, Abstract] 
12. Mental Health [Title, Abstract] 
13. 1 OR 2 OR 3 OR 4 
14. 5 OR 6 OR 7 OR 8 
15. 9 OR 10 OR 11 OR 12 
16. 13 AND 14 
17. 13 AND 15 
18. 15 AND 16 
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